The Department of Pharmaceuticals (DoP) has directed the National Pharmaceutical Pricing Authority (NPPA) to revalidate the data under para 9(1) of DPCO 2013 by appropriate survey or evaluation and ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results